Literature DB >> 29065385

Insights into immune tolerance from AIRE deficiency.

Irina Proekt1, Corey N Miller1, Michail S Lionakis2, Mark S Anderson3.   

Abstract

AIRE is a well-established master regulator of central tolerance. It plays an essential role in driving expression of tissue-specific antigens in the thymus and shaping the development of positively selected T-cells. Humans and mice with compromised or absent AIRE function have markedly variable phenotypes that include a range of autoimmune manifestations. Recent evidence suggests that this variability stems from cooperation of autoimmune susceptibilities involving both central and peripheral tolerance checkpoints. Here we discuss the broadening understanding of the factors that influence Aire expression, modify AIRE function, and the impact and intersection of AIRE with peripheral immunity. This rapidly expanding body of knowledge will force a reexamination of the definition and clinical management of APS-1 patients as well as provide a foundation for the development of immunomodulatory strategies targeting central tolerance.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29065385      PMCID: PMC5705335          DOI: 10.1016/j.coi.2017.10.003

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  53 in total

Review 1.  A central role for central tolerance.

Authors:  Bruno Kyewski; Ludger Klein
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

2.  Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Elise M N Ferre; Stacey R Rose; Sergio D Rosenzweig; Peter D Burbelo; Kimberly R Romito; Julie E Niemela; Lindsey B Rosen; Timothy J Break; Wenjuan Gu; Sally Hunsberger; Sarah K Browne; Amy P Hsu; Shakuntala Rampertaap; Muthulekha Swamydas; Amanda L Collar; Heidi H Kong; Chyi-Chia Richard Lee; David Chascsa; Thomas Simcox; Angela Pham; Anamaria Bondici; Mukil Natarajan; Joseph Monsale; David E Kleiner; Martha Quezado; Ilias Alevizos; Niki M Moutsopoulos; Lynne Yockey; Cathleen Frein; Ariane Soldatos; Katherine R Calvo; Jennifer Adjemian; Morgan N Similuk; David M Lang; Kelly D Stone; Gulbu Uzel; Jeffrey B Kopp; Rachel J Bishop; Steven M Holland; Kenneth N Olivier; Thomas A Fleisher; Theo Heller; Karen K Winer; Michail S Lionakis
Journal:  JCI Insight       Date:  2016-08-18

Review 3.  Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential.

Authors:  Padmanee Sharma; James P Allison
Journal:  Cell       Date:  2015-04-09       Impact factor: 41.582

4.  Detection of an autoreactive T-cell population within the polyclonal repertoire that undergoes distinct autoimmune regulator (Aire)-mediated selection.

Authors:  Ruth T Taniguchi; Jason J DeVoss; James J Moon; John Sidney; Alessandro Sette; Marc K Jenkins; Mark S Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-02       Impact factor: 11.205

Review 5.  Monogenic autoimmunity.

Authors:  Mickie H Cheng; Mark S Anderson
Journal:  Annu Rev Immunol       Date:  2012-01-06       Impact factor: 28.527

6.  T-cell regulation by casitas B-lineage lymphoma (Cblb) is a critical failsafe against autoimmune disease due to autoimmune regulator (Aire) deficiency.

Authors:  Charis E Teh; Stephen R Daley; Anselm Enders; Christopher C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-28       Impact factor: 11.205

7.  Canonical microRNAs in thymic epithelial cells promote central tolerance.

Authors:  Imran S Khan; Ruth T Taniguchi; Kayla J Fasano; Mark S Anderson; Lukas T Jeker
Journal:  Eur J Immunol       Date:  2014-03-20       Impact factor: 5.532

8.  Sex hormones have pervasive effects on thymic epithelial cells.

Authors:  Maude Dumont-Lagacé; Charles St-Pierre; Claude Perreault
Journal:  Sci Rep       Date:  2015-08-07       Impact factor: 4.379

9.  Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1.

Authors:  Nils Landegren; Donald Sharon; Eva Freyhult; Åsa Hallgren; Daniel Eriksson; Per-Henrik Edqvist; Sophie Bensing; Jeanette Wahlberg; Lawrence M Nelson; Jan Gustafsson; Eystein S Husebye; Mark S Anderson; Michael Snyder; Olle Kämpe
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

10.  Intronic regulation of Aire expression by Jmjd6 for self-tolerance induction in the thymus.

Authors:  Toyoshi Yanagihara; Fumiyuki Sanematsu; Tetsuya Sato; Takehito Uruno; Xuefeng Duan; Takahiro Tomino; Yosuke Harada; Mayuki Watanabe; Yuqing Wang; Yoshihiko Tanaka; Yoichi Nakanishi; Mikita Suyama; Fukui Yoshinori
Journal:  Nat Commun       Date:  2015-11-04       Impact factor: 14.919

View more
  17 in total

1.  Lymphocyte-driven regional immunopathology in pneumonitis caused by impaired central immune tolerance.

Authors:  Elise M N Ferré; Timothy J Break; Peter D Burbelo; Michael Allgäuer; David E Kleiner; Dakai Jin; Ziyue Xu; Les R Folio; Daniel J Mollura; Muthulekha Swamydas; Wenjuan Gu; Sally Hunsberger; Chyi-Chia R Lee; Anamaria Bondici; Kevin W Hoffman; Jean K Lim; Kerry Dobbs; Julie E Niemela; Thomas A Fleisher; Amy P Hsu; Laquita N Snow; Dirk N Darnell; Samar Ojaimi; Megan A Cooper; Martin Bozzola; Gary I Kleiner; Juan C Martinez; Robin R Deterding; Douglas B Kuhns; Theo Heller; Karen K Winer; Arun Rajan; Steven M Holland; Luigi D Notarangelo; Kevin P Fennelly; Kenneth N Olivier; Michail S Lionakis
Journal:  Sci Transl Med       Date:  2019-06-05       Impact factor: 17.956

Review 2.  Lessons from primary immunodeficiencies: Autoimmune regulator and autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.

Authors:  Gregory M Constantine; Michail S Lionakis
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

3.  Mycophenolate-Induced Colitis in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Patients.

Authors:  Monica M Schmitt; Elise M N Ferré; Michelly Sampaio De Melo; Megan A Cooper; Martha M Quezado; Theo Heller; Michail S Lionakis
Journal:  JPGN Rep       Date:  2021-11

Review 4.  Infections in the monogenic autoimmune syndrome APECED.

Authors:  Vasileios Oikonomou; Timothy J Break; Sarah L Gaffen; Niki M Moutsopoulos; Michail S Lionakis
Journal:  Curr Opin Immunol       Date:  2021-08-18       Impact factor: 7.268

5.  Retracing the evolutionary emergence of thymopoiesis.

Authors:  Jeremy B Swann; Anja Nusser; Ryo Morimoto; Daisuke Nagakubo; Thomas Boehm
Journal:  Sci Adv       Date:  2020-11-27       Impact factor: 14.136

Review 6.  Regulatory Role of CD4+ T Cells in Myocarditis.

Authors:  Daria Vdovenko; Urs Eriksson
Journal:  J Immunol Res       Date:  2018-06-21       Impact factor: 4.818

Review 7.  Microbiome and Autoimmune Uveitis.

Authors:  Reiko Horai; Rachel R Caspi
Journal:  Front Immunol       Date:  2019-02-19       Impact factor: 7.561

8.  Dual functions of Aire CARD multimerization in the transcriptional regulation of T cell tolerance.

Authors:  Yu-San Huoh; Bin Wu; Sehoon Park; Darren Yang; Kushagra Bansal; Emily Greenwald; Wesley P Wong; Diane Mathis; Sun Hur
Journal:  Nat Commun       Date:  2020-04-02       Impact factor: 14.919

Review 9.  Biological characteristics of transcription factor RelB in different immune cell types: implications for the treatment of multiple sclerosis.

Authors:  Meng-Ge Yang; Li Sun; Jinming Han; Chao Zheng; Hudong Liang; Jie Zhu; Tao Jin
Journal:  Mol Brain       Date:  2019-12-27       Impact factor: 4.041

10.  Nfkb2 variants reveal a p100-degradation threshold that defines autoimmune susceptibility.

Authors:  Rushika C Wirasinha; Ainsley R Davies; Monika Srivastava; Julie M Sheridan; Xavier Y X Sng; Ottavia M Delmonte; Kerry Dobbs; Khai L Loh; Lisa A Miosge; Cindy Eunhee Lee; Rochna Chand; Anna Chan; Jin Yan Yap; Michael D Keller; Karin Chen; Jamie Rossjohn; Nicole L La Gruta; Carola G Vinuesa; Hugh H Reid; Michail S Lionakis; Luigi D Notarangelo; Daniel H D Gray; Christopher C Goodnow; Matthew C Cook; Stephen R Daley
Journal:  J Exp Med       Date:  2021-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.